Latest Trials


EudraCT Number: 2017-003220-78 Sponsor Protocol Number: I8B-MC-ITSA Start Date:
Sponsor Name: Eli Lilly and Company
Full Title: A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog in Children, Adolescents, and Adults with Type 1 Diabetes Mellitus
Medical condition: Diabetes Mellitus, Type 1
Disease: Version SOC Term Classification Code Term Level
20.0 10027433 - Metabolism and nutrition disorders 10012601 Diabetes mellitus PT
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2014-002442-45 Sponsor Protocol Number: AXAFA-AFNET5 Start Date:
Sponsor Name: Kompetenznetz Vorhofflimmern e.V. [Atrial Fibrillation NETwork (AFNET)]
Full Title: Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy.
Medical condition: Atrial fibrillation catheter ablation
Disease: Version SOC Term Classification Code Term Level
19.0 10007541 - Cardiac disorders 10003658 Atrial fibrillation PT
19.0 10007541 - Cardiac disorders 10071667 Persistent atrial fibrillation LLT
19.0 10007541 - Cardiac disorders 10003661 Atrial fibrillation paroxysmal LLT
19.0 10007541 - Cardiac disorders 10066582 Recurrent atrial fibrillation LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) BE (Completed) DK (Completed) GB (Completed) NL (Completed) ES (Completed) AT (Completed)
Trial results: (No results available)
EudraCT Number: 2006-006907-35 Sponsor Protocol Number: SP915 Start Date:
Sponsor Name: Schwarz Biosciences GmbH
Full Title: Long-term extension of RECOVER A MULTICENTER, MULTINATIONAL, PHASE 3B, OPEN-LABEL EXTENSION TRIAL TO EVALUATE THE LONG-TERM EFFECT OF THE 24-HOUR TRANSDERMAL DELIVERY OF ROTIGOTINE ON MOTOR FUNCTI...
Medical condition: Parkinson's disease
Disease: Version SOC Term Classification Code Term Level
9.1 10061536 Parkinson's disease LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended) FI (Completed) ES (Completed) HU (Completed) IT (Completed) GB (Completed) AT (Prematurely Ended)
Trial results: View results

EudraCT Number: 2005-005641-19 Sponsor Protocol Number: ENG K001 GF / EC 406 Start Date:
Sponsor Name: Takeda Pharma GmbH
Full Title: 3 Months, Open-Label, Parallel-Group Study of the Pharmacodynamics, Pharmacokinetics and Safety of TAP-144SR 1-month Depot Gelatin-Free vs. Gelatin-Containing Formulation in Female Patients with Ut...
Medical condition: Uterine fibroids (Uterus myomatosus)
Disease: Version SOC Term Classification Code Term Level
8.0 10046784 LLT
Population Age: Adults Gender: Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2019-003676-39 Sponsor Protocol Number: 109147 Start Date:
Sponsor Name:
Full Title: Effects of sodium lactate infusion in patients with glucose transporter 1 deficiency syndrome (GLUT1DS)
Medical condition: In glucose transporter 1 deficiency syndrome (GLUT1DS) cerebral glucose uptake from the systemic blood circulation is limited, because of deficient transport of glucose across the blood-brain barri...
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-006912-31 Sponsor Protocol Number: AMV-12_12_2006 Start Date:
Sponsor Name: Universitätsklinikum Schleswig-Holstein
Full Title: Vereidung maschineller Beatmung bei sehr kleinen Frühgeborenen - Avoid mechanical ventilation (The AMV-Trial)
Medical condition: Respiratory distress syndrom of preterm infants (ICD 10: P22.0)
Disease: Version SOC Term Classification Code Term Level
Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
Trial protocol: DE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2019-000205-77 Sponsor Protocol Number: KF5503-75 Start Date:
Sponsor Name: Grünenthal GmbH
Full Title: Open-label investigation of the pharmacokinetic profile, safety, tolerability, and efficacy of multiple administrations of tapentadol oral solution used for treatment of acute pain in children aged...
Medical condition: Moderate to severe acute pain
Disease: Version SOC Term Classification Code Term Level
20.1 100000004867 10066714 Acute pain LLT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: PL (Completed)
Trial results: View results

EudraCT Number: 2020-002046-16 Sponsor Protocol Number: MARS_2020 Start Date:
Sponsor Name: Fakultní nemocnice Brno
Full Title: A Randomised, double-blinded, placebo-controlled, multicenter study of efficacy, safety and side effects of highly diluted atropine collyrium in slowing the progression of myopia (shortsightedness)...
Medical condition: Myopia in children
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: CZ (Ongoing)
Trial results: (No results available)
EudraCT Number: 2017-003643-38 Sponsor Protocol Number: 17-HPNCL-01 Start Date:
Sponsor Name: Fondation Lenval - Hôpitaux Pédiatriques de Nice CHU-LENVAL
Full Title: INTRANASAL KETAMINE IN THE REDUCTION OF THE ISOLATED FRACTURES OF THE HIGHER MEMBER OF THE CHILD TO PEDIATRIC EMERGENCIES
Medical condition: a fracture isolated from the distal end of the closed upper limb, requiring a reduction
Disease: Version SOC Term Classification Code Term Level
20.0 10022117 - Injury, poisoning and procedural complications 10016997 Forearm fracture PT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2017-004207-52 Sponsor Protocol Number: CQGE031C2202 Start Date:
Sponsor Name: Novartis Pharma AG
Full Title: A multicenter, randomized, double-blind, placebo-controlled phase 2b dose-finding study to investigate the efficacy and safety of ligelizumab (QGE031) in adolescent patients with Chronic Spontaneou...
Medical condition: Chronic Spontaneous Urticaria
Disease: Version SOC Term Classification Code Term Level
20.0 10040785 - Skin and subcutaneous tissue disorders 10072757 Chronic spontaneous urticaria PT
Population Age: Adolescents, Under 18 Gender: Male, Female
Trial protocol: DE (Completed) ES (Completed) BE (Completed) HU (Completed) EE (Completed)
Trial results: View results